TY  - GEN
AU  - O'Shaughnessy,J A
AU  - Denicoff,A M
AU  - Venzon,D J
AU  - Danforth,D
AU  - Pierce,L J
AU  - Frame,J N
AU  - Bastian,A
AU  - Ghosh,B
AU  - Goldspiel,B
AU  - Miller,L
TI  - A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients
SN  - 0923-7534
PY  - 1995///0223
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Dyspnea
KW  - etiology
KW  - Escherichia coli
KW  - Fluorouracil
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - adverse effects
KW  - Humans
KW  - Hypotension
KW  - Leucovorin
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neutropenia
KW  - chemically induced
KW  - Recombinant Proteins
KW  - Regression Analysis
KW  - Remission Induction
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1093/oxfordjournals.annonc.a058975
ER  -